{"title":"2022年初临床肿瘤学研究亮点。","authors":"Kaichun Wu","doi":"10.1007/s44178-022-00006-9","DOIUrl":null,"url":null,"abstract":"<p><p>Advance in clinical oncology is highly relied on development of cancer research and clinical trials. There has been ample evidence regarding the new therapeutic drugs, agents or techniques for the treatment of cancer. We did a broad literature search to catch the latest progress in the cancer therapy. Here is a brief review of the newly released results of clinical trials including surgical modalities, immune checkpoint blockade, chimeric antigen receptor T-cell (CAR T) therapy, antibody-drug conjugates and tumor vaccines, etc. Biomarkers or patient assessment of cancer therapy were also discussed.</p>","PeriodicalId":73245,"journal":{"name":"Holistic integrative oncology","volume":"1 1","pages":"6"},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255546/pdf/","citationCount":"0","resultStr":"{\"title\":\"Research highlights of clinical oncology early 2022.\",\"authors\":\"Kaichun Wu\",\"doi\":\"10.1007/s44178-022-00006-9\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Advance in clinical oncology is highly relied on development of cancer research and clinical trials. There has been ample evidence regarding the new therapeutic drugs, agents or techniques for the treatment of cancer. We did a broad literature search to catch the latest progress in the cancer therapy. Here is a brief review of the newly released results of clinical trials including surgical modalities, immune checkpoint blockade, chimeric antigen receptor T-cell (CAR T) therapy, antibody-drug conjugates and tumor vaccines, etc. Biomarkers or patient assessment of cancer therapy were also discussed.</p>\",\"PeriodicalId\":73245,\"journal\":{\"name\":\"Holistic integrative oncology\",\"volume\":\"1 1\",\"pages\":\"6\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255546/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Holistic integrative oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/s44178-022-00006-9\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2022/7/5 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Holistic integrative oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s44178-022-00006-9","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/7/5 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
Research highlights of clinical oncology early 2022.
Advance in clinical oncology is highly relied on development of cancer research and clinical trials. There has been ample evidence regarding the new therapeutic drugs, agents or techniques for the treatment of cancer. We did a broad literature search to catch the latest progress in the cancer therapy. Here is a brief review of the newly released results of clinical trials including surgical modalities, immune checkpoint blockade, chimeric antigen receptor T-cell (CAR T) therapy, antibody-drug conjugates and tumor vaccines, etc. Biomarkers or patient assessment of cancer therapy were also discussed.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
